Ethical Considerations

 | Post date: 2017/02/4 | 

Authorship and Acknowledgements

The journal adheres to the definition of authorship set up by The International Committee of Medical Journal Editors (ICMJE). The ICMJE recommends that authorship be based on the following 4 criteria: i) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; ii) Drafting the work or revising it critically for important intellectual content; iii) Final approval of the version to be published; and iv) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Contributors who do not qualify as authors should be mentioned under ‘Acknowledgements’.

At the time of submission, the submitting author must include a disclosure statement in the body of the manuscript. All authors are required to disclose all potential conflicts of interest, including specific financial interests and relationships and affiliations (other than those affiliations listed in the title page of the manuscript) relevant to the subject of their manuscript. This information should be provided under the heading titled ‘Conflicts of interest’ which should appear after the ‘Author contributions’ section and before the ‘References’ section. Authors without conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject of their manuscript, should include a statement of no such interests in the Disclosure section of the manuscript. Failure to include this information in the manuscript may delay evaluation and review of the manuscript.

Principles for Publication of Research Involving Human Subjects

Manuscripts must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the Declaration of Helsinki (as revised in Brazil 2013), available at It should also state clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under the study should be omitted. Photographs need to be cropped sufficiently to prevent human subjects being recognized (or an eye bar should be used).

In general, submission of a case report should be accompanied by the written consent of the subject (or parent/guardian) before publication; this is particularly important where photographs are to be used or in cases where the unique nature of the incident reported makes it possible for the patient to be identified. While the Editorial Board recognizes that it might not always be possible or appropriate to seek such consent, the onus will be on the authors to demonstrate that this exception applies in their case.

Any experiments involving animals must be demonstrated to be ethically acceptable and must conform to international guidelines for animal usage in research, such as those of the US NIH or the UK Home Office.

Clinical Trials Registry

We require, as a condition of consideration for publication, registration in a public trials registry. Trials must register at or before the onset of patient enrollment. This policy applies to any clinical trial starting enrollment after January 1, 2006. For trials that began enrollment before this date, we require registration by April 1, 2006, before considering the trial for publication. We define a clinical trial as any research project that prospectively assigns human subjects to intervention or comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome. Studies designed for other purposes, such as to study pharmacokinetics or major toxicity (e.g., phase 1 trials) are exempt.

We do not advocate one particular registry, but registration must be with a registry that meets the following minimum criteria: (1) accessible to the public at no charge; (2) searchable by standard, electronic (Internet-based) methods; (3) open to all prospective registrants free of charge or at minimal cost; (4) validates registered information; (5) identifies trials with a unique number; and (6) includes information on the investigator(s), research question or hypothesis, methodology, intervention and comparisons, eligibility criteria, primary and secondary outcomes measured, date of registration, anticipated or actual start date, anticipated or actual date of last follow-up, target number of subjects, status (anticipated, ongoing or closed) and funding source(s).

Registries that currently meet these criteria include: (1) the registry sponsored by the United States National Library of Medicine; (2) the International Standard Randomized Controlled Trial Number Registry; (3) the Australian New Zealand Clinical Trials Registry (ANZCTR); (4) the Chinese Clinical Trials Register; (5) the Clinical Trials Registry - India and (6) the Iranian Clinical Trial Registration (www.IRCT.IR).

Randomized control trials
Reporting of randomized controlled trials should follow the guidelines of The CONSORT Statement.

Committee on Publication Ethics. The journal still is not a member of the Committee on Publication Ethics (COPE), but we are committed to implementing the principles of it. We're trying to be a member in the future.
Complaints Procedures
We hope no complaints will be made. But if it happens, we will try to put it on the agenda immediately. The complainant must be aware that the subject cannot be investigated unless the corresponding author/ author and possibly the institution or company at which the research took place be informed about the complaint. The following procedures are followed:
How to Make a Complaint
  • The best way to contact us is by email ( Complaints should clearly contain the topic, person, or event related to the JNFS.
  • Whenever possible, complaints will be processed by the relevant member of the Editorial Board. If that person cannot deal with the complaint, it will be referred to the Editorial Board of JNFS.
  • Complaints that are not under the control of the JNFS Editorial Board will be sent to School of Public Health Research Ethic Committee. Finally, if complaints are not resolved in the School committee, it will be sent to Shahid Sadoughi University Research Ethics Committee.
  • If possible, a full response will be made within four weeks. If this is not possible, an interim response will be given within four weeks. Further, interim responses will be provided until the complaint is resolved.
  • If the complainant remains unhappy, complaints should be sent to the chancellor of Shahid Sadoughi University of Medical Sciences, whose decision ends the procedure.
  • If a complainant remains unhappy after the chancellor’s final decision, he/she may complain to The Committee on Publication Ethics (COPE). The Committee on Publication Ethics publishes a code of practice for editors of scientific, technical, and medical journals It will consider complaints when a journal cannot reach an agreement through its own procedures.
Ethics of scientific publication
Duplicate Submission: Submission of a manuscript implies that it has neither been submitted nor under consideration for publication elsewhere. Manuscripts found to be submitted or under review elsewhere will incur duplicate submission sanctions. The copyright holder's permission must be obtained if previously published tables, illustrations, or texts are included. Previously published material can be cited in a later review or commentary article, but it must be indicated, using quotation marks if necessary.
Duplicate Publication: Manuscripts published elsewhere with the same intellectual material are considered as duplicate publication. If authors have used their own previously published paper, or work that is currently under review as a basis for the submitted manuscript, they are required to cite the previous work. They should also indicate that their submitted manuscript offers novel contributions beyond those of the previous work.
Selective Reporting of Data: Selective reporting of data is inappropriate, especially if unreported data are in disagreement with the findings of the selectively reported data. In accordance with the ICMJE, the JNFS supports publication of studies with negative and contrasting results. The literature review should contain publications relevant to the uniqueness of the research whether composed by other researchers or the present authors. Previous publication of a preliminary report on the data is permissible, if it is stated clearly as a footnote.
Scientific Misconducts
Fabrication: Fabrication is the intentional misrepresentation of research results by making up data, such as the one reported in a journal article. JNFS journal will ask the author(s) to provide the raw data for further investigations if necessary.
Falsification: It is manipulating research materials, equipment, or processes or changing or omitting data or results such that the research is not accurately represented in the research record. In the initial process of peer review, JNFS journal tries to consider this issue and act accordingly.
Plagiarism: Plagiarism of text from a previously published manuscript by the same or another author is a serious publication offence. Small amounts of text may be used, but only where the source of the material is quoted and clearly acknowledged. Fraudulent data or data stolen from other authors are also unethical and will be treated accordingly. Any alleged offence is considered initially by the Editorial Board using suitable software and in the case of proved plagiarism, the author(s) will be informed and the manuscript will be rejected.
Retraction Policy: The JNFS uses the COPE flowchart for retraction of a published article.

View: 4004 Time(s)   |   Print: 326 Time(s)   |   Email: 0 Time(s)   |   0 Comment(s)

© 2015 All Rights Reserved | Journal of Nutrition and Food Security

Designed & Developed by : Yektaweb